Microgenics

Microgenics, a subsidiary of Thermo Fisher Scientific, is a leading developer and manufacturer of clinical diagnostic products, specializing in high-performance immunoassays. The company is recognized for its innovative technology platforms, including Cloned Enzyme Donor Immunoassay (CEDIA), Diagnostic Reagents Inc. (DRI), and Quantitative Microsphere System (QMS). These technologies are utilized globally for drugs of abuse testing, therapeutic drug monitoring, and specialty diagnostics in clinical and forensic laboratories. Based in Fremont, California, Microgenics provides a comprehensive range of reagents, calibrators, and controls that ensure accuracy and efficiency in laboratory testing. Their portfolio supports critical medical areas such as organ transplantation, neurology, and toxicology. By delivering reliable diagnostic solutions, Microgenics plays a vital role in improving patient outcomes and laboratory productivity.